These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3781919)

  • 1. Triacsins, new inhibitors of acyl-CoA synthetase produced by Streptomyces sp.
    Omura S; Tomoda H; Xu QM; Takahashi Y; Iwai Y
    J Antibiot (Tokyo); 1986 Sep; 39(9):1211-8. PubMed ID: 3781919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for an essential role of long chain acyl-CoA synthetase in animal cell proliferation. Inhibition of long chain acyl-CoA synthetase by triacsins caused inhibition of Raji cell proliferation.
    Tomoda H; Igarashi K; Cyong JC; Omura S
    J Biol Chem; 1991 Mar; 266(7):4214-9. PubMed ID: 1999415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of acyl-CoA synthetase by triacsins.
    Tomoda H; Igarashi K; Omura S
    Biochim Biophys Acta; 1987 Oct; 921(3):595-8. PubMed ID: 3117118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid metabolism inhibitors of microbial origin.
    Tomoda H; Omura S
    Kitasato Arch Exp Med; 1993 Apr; 65 Suppl():1-12. PubMed ID: 7967370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triacsin C: a differential inhibitor of arachidonoyl-CoA synthetase and nonspecific long chain acyl-CoA synthetase.
    Hartman EJ; Omura S; Laposata M
    Prostaglandins; 1989 Jun; 37(6):655-71. PubMed ID: 2505330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Triacsins, inhibitors of fatty acid activating enzyme].
    Tomoda H; Omura S
    Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1929-37. PubMed ID: 8210435
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-atherosclerotic activity of triacsin C, an acyl-CoA synthetase inhibitor.
    Matsuda D; Namatame I; Ohshiro T; Ishibashi S; Omura S; Tomoda H
    J Antibiot (Tokyo); 2008 May; 61(5):318-21. PubMed ID: 18653998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying the Biosynthetic Gene Cluster for Triacsins with an N-Hydroxytriazene Moiety.
    Twigg FF; Cai W; Huang W; Liu J; Sato M; Perez TJ; Geng J; Dror MJ; Montanez I; Tong TL; Lee H; Zhang W
    Chembiochem; 2019 May; 20(9):1145-1149. PubMed ID: 30589194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis of triacsin featuring an N-hydroxytriazene pharmacophore.
    Del Rio Flores A; Twigg FF; Du Y; Cai W; Aguirre DQ; Sato M; Dror MJ; Narayanamoorthy M; Geng J; Zill NA; Zhai R; Zhang W
    Nat Chem Biol; 2021 Dec; 17(12):1305-1313. PubMed ID: 34725510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acyl-CoA synthetase inhibitor triacsin C enhanced eicosanoid release in leukocytes.
    Oh-ishi S; Yamaki K; Abe M; Tomoda H; Omura S
    Jpn J Pharmacol; 1992 Jul; 59(3):417-8. PubMed ID: 1434135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete inhibition of mouse macrophage-derived foam cell formation by triacsin C.
    Namatame I; Tomoda H; Arai H; Inoue K; Omura S
    J Biochem; 1999 Feb; 125(2):319-27. PubMed ID: 9990129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced production of platelet-activating factor in stimulated rat leukocytes pretreated with triacsin C, A novel acyl-coA synthetase inhibitor.
    Hayashi M; Imai Y; Naraba H; Tomoda H; Omura S; Oh-ishi S
    Biochem Biophys Res Commun; 1992 Nov; 188(3):1280-5. PubMed ID: 1445360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting long-chain fatty acyl CoA synthetase does not increase agonist-induced release of arachidonate metabolites from human endothelial cells.
    Weis MT; Brady M; Moore M; Crumley J; Stallone JN
    J Vasc Res; 2005; 42(4):275-83. PubMed ID: 15908751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of triacsin C inhibition of short-, medium-, and long-chain fatty acid: CoA ligases of human liver.
    Vessey DA; Kelley M; Warren RS
    J Biochem Mol Toxicol; 2004; 18(2):100-6. PubMed ID: 15122652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human intestinal acyl-CoA synthetase 5 is sensitive to the inhibitor triacsin C.
    Kaemmerer E; Peuscher A; Reinartz A; Liedtke C; Weiskirchen R; Kopitz J; Gassler N
    World J Gastroenterol; 2011 Nov; 17(44):4883-9. PubMed ID: 22171129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on new vasodilators, WS-1228 A and B. II. Structure and synthesis.
    Tanaka H; Yoshida K; Itoh Y; Imanaka H
    J Antibiot (Tokyo); 1982 Feb; 35(2):157-63. PubMed ID: 6804426
    [No Abstract]   [Full Text] [Related]  

  • 17. WS-9659 A and B, novel testosterone 5 alpha-reductase inhibitors isolated from a Streptomyces. I. Taxonomy, fermentation, isolation, physico-chemical characteristics.
    Nakayama O; Yagi M; Tanaka M; Kiyoto S; Okuhara M; Kohsaka M
    J Antibiot (Tokyo); 1989 Aug; 42(8):1221-9. PubMed ID: 2759904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting long chain fatty Acyl CoA synthetase increases basal and agonist-stimulated NO synthesis in endothelium.
    Weis MT; Crumley JL; Young LH; Stallone JN
    Cardiovasc Res; 2004 Aug; 63(2):338-46. PubMed ID: 15249192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of Cryptosporidium parvum infection in vitro and in vivo by targeting parasite fatty acyl-coenzyme A synthetases.
    Guo F; Zhang H; Fritzler JM; Rider SD; Xiang L; McNair NN; Mead JR; Zhu G
    J Infect Dis; 2014 Apr; 209(8):1279-87. PubMed ID: 24273180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lustromycin, a new antibiotic produced by Streptomyces sp.
    Tomoda H; Iwata R; Takahashi Y; Iwai Y; Oiwa R; Omura S
    J Antibiot (Tokyo); 1986 Sep; 39(9):1205-10. PubMed ID: 3781918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.